相关实验视频

Updated: Sep 15, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

在中国的不孕症患者中,愿意为辅助生殖技术付费

Chaofan Li¹, Hongbin Cong², Stephen Jan³

¹Department of Social Medicine and Health Management, School of Public Health, Cheeloo College of Medicine, Shandong University; NHC Key Lab of Health Economics and Policy Research (Shandong University); Center for Health Management and Policy Research, Shandong University (Shandong Provincial Key New Think Tank); Center for Health Preference Research, Shandong University, Jinan, Shandong Province, 250012, China.

Health policy and planning

|July 17, 2025

概括

在中国,不孕症患者显著愿意支付辅助生殖技术 (ART) 的费用. 这些发现可以为保险公司提供信息,以改善获得诸如体外受精 (IVF) 等生育治疗的机会.

科学领域:

生殖医学与经济学
低收入和中等收入国家 (LMICs) 的公共卫生融资

背景情况:

不孕症是一个全球性的健康问题,具有重大的经济影响.
辅助生殖技术 (ART) 是有效的,但在LMICs,公共卫生融资往往不涵盖.
中国的出生率下降需要了解对ART的支付意愿 (WTP),以指导保险政策.

研究的目的:

评估在中国经历不孕症的个体中支付辅助生殖技术 (ART) 的意愿 (WTP).
提供数据,以确定ART服务的成本效益门和报销政策.

主要方法:

在5个不同的中国医院中,对570名不孕症患者进行了横截面调查.
配额抽样被用于参与者招聘.
一种附带估值方法提出了体外受精 (IVF),人工授精 (AI) 和植入前遗传测试 (PGT) 的假设场景.

主要成果:

受访者表示愿意支付30163元人民币用于试管婴儿,6046元人民币用于人工智能,47234元人民币用于PGT.
这些数额分别是中国人均GDP的0.34,0.07,0.53倍.
与较低WTP相关的因素包括年龄较大和男性因素/不明原因的不育;高等教育和与医生沟通的成本与较高的WTP有关.

结论:

中国的公共医疗保险应该为ART设定适当的成本效益值和赔偿上限,以提高负担能力和获取能力.
整合患者和医生之间的成本讨论可以改善共享决策和ART的感知价值.

关键词:

愿意支付的意愿.卫生经济学卫生经济学患者患者患者患者患者患者患者

更多相关视频

Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis

Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis

Published on: September 7, 2021

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

相关概念视频

Infertility in Males

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...

Infertility in Females

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...

In Vitro Fertilization

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...